Key result
The (CT)n=6 allele in the 5'-flanking region of the GC-A gene was significantly associated with essential hypertension in Japanese subjects (OR 5.31).
Why the study?
Is the CT dinucleotide repeat polymorphism in the GC-A gene associated with essential hypertension in Japanese subjects?
Case-Control (n=347)
Is the CT dinucleotide repeat polymorphism in the GC-A gene associated with essential hypertension in Japanese subjects?
Odds Ratio: 5.31 (95% CI 1.1–25.6)
Absolute Event Rate: 2.8% vs 0.6%
p-value: p=0.037
The (CT)n=6 polymorphism in the GC-A gene is a novel susceptibility marker for essential hypertension in the Japanese population, acting synergistically with a G/A polymorphism to reduce promoter activity.
Guanylyl cyclase (GC)-A (natriuretic peptide receptor [NPR]-1), the receptor for atrial and brain natriuretic peptide, is important in the regulation of blood pressure in animal models and, possibly, in humans. In this study, we examined the association between dinucleotide repeat polymorphism within the 5'-flanking region of the GC-A gene and essential hypertension in a group of Japanese subjects. By genotyping 177 hypertensive and 170 normotensive subjects, we identified 5 allele types with 6, 9, 10, 11 and 12 CT dinucleotide repeats, respectively, around position -293, upstream of the ATG codon in the human GC-A gene. The frequency of the (CT)n=6 allele was significantly higher among hypertensive than normotensive subjects, while the frequencies of the other allele types did not differ between the two groups. We also examined the linkage between G/A polymorphism at position -77 (rs13306004), downstream of the (CT)n polymorphism, and found that the (CT)n=6 allele was tightly linked to an A at position -77, while all other (CT)n alleles were linked to G. Promoter-reporter analyses carried out in cultured human aortic smooth muscle cells using a luciferase gene fused to the 5'-flanking region of the GC-A gene revealed that the promoter containing (CT)n=6 drove less transcriptional activity than that containing (CT)n=10. Finally, site-directed mutation showed that the (CT)n and G/A polymorphisms act synergistically to affect GC-A promoter activity. Our results thus define the (CT)n polymorphism in the 5'-flanking region of the GC-A gene as a potent and novel susceptibility marker for hypertension.
No takes yet. Share an insight, caveat, or question.
Usami et al. (2008) conducted a case-control in Essential hypertension (n=347). (CT)n=6 allele at position -293 of the GC-A gene vs. Absence of the (CT)n=6 allele was evaluated on Essential hypertension (OR 5.31, 95% CI 1.10-25.6, p=0.037). The (CT)n=6 allele in the 5'-flanking region of the GC-A gene was significantly associated with essential hypertension in Japanese subjects (OR 5.31).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: